Capsule transplant for newly diagnosed type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 1 diabetes within the last 100 days
- Between 18 and 45 years old
- Body mass index (BMI) between 18 and 30
- Still making some insulin (C-peptide detectable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
This trial tests if a fecal microbiota transplant can help people with both type 2 diabetes and Hashimoto's thyroiditis. It aims to see if changing gut bacteria can improve blood sugar and thyroid health.
This trial tests if a washed microbiota transplant (a processed stool transplant from healthy donors) can help people with type 1 diabetes. It aims to see if this treatment can improve blood sugar control or reduce the need for insulin.
This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.
This pilot study tests whether a fecal microbiota transplant (putting healthy donor stool into the colon) can improve health in people with type 2 diabetes and stable coronary artery disease. It will help researchers see if changing gut bacteria can help manage both conditions.
Hear when a new Type 1 Diabetes Mellitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.